L. S. Kamaraju1
P. H. Levine1
S. Belhassen1
F. Tabbane1
L. R. Muenz1
1L. S. Kamaraju
1P. H. Levine
1S. Belhassen
Learn More
112 Tunisian patients with rapidly progressing breast cancer (RPBC) were entered into a clinical trial evaluating combination chemotherapy as a primary form of treatment before surgery or radiotherapy. Three cycles of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) were administered at monthly intervals; patients were then randomized to surgery or(More)
  • 1